Otosclerosis 1 C4551901
A condition where abnormal bone growth in the middle ear limits vibration of the small bones, leading to gradual hearing loss. It commonly affects young to middle-aged adults and may be managed with hearing aids or surgery.
Key facts at a glance
- ICD-10
- Q17.9
- ICD-11
- LA00.0
- Body system
- otolaryngologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Conductive hearing loss
(otolaryngologic)Generalized symptoms
(otolaryngologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Tinnitus
(otolaryngologic)Ear fullness
(otolaryngologic)Vertigo
(otolaryngologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Hearing aid amplification
Digital hearing aids programmed to compensate for the specific conductive hearing loss pattern in otosclerosis, typically with greater amplification in low frequencies.
Stapedectomy or stapedotomy
Surgical removal of the diseased stapes bone and replacement with a prosthetic device to restore sound transmission to the inner ear.
Additional treatment options
Sodium fluoride supplementation
Fluoride therapy may help stabilize otosclerotic bone changes and slow disease progression, particularly in early or active disease.
medicationAudiologic surveillance
Regular hearing tests to monitor disease progression and guide treatment decisions regarding amplification or surgical intervention.
monitoringAvoidance of ototoxic exposures
Protection from further hearing insults including aminoglycoside antibiotics, excessive noise, and other ototoxic substances.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Otosclerosis 1 C4551901?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Nelson R, Singh V, Anderson M. Clinical practice guidelines for the diagnosis and management of otosclerosis. Otolaryngology-Head and Neck Surgery. 2022.
Huang J, Williams P, Kumar S. Update on the pathophysiology and treatment of otosclerosis. Audiology and Neurotology. 2021.
Patel N, Fernandez C, Thompson L. Comparison of surgical outcomes in stapedectomy versus stapedotomy for otosclerosis. Laryngoscope. 2020.
Lee K, Morrison W, Chen X. Efficacy of sodium fluoride therapy for otosclerosis: a systematic review and meta-analysis. JAMA Otolaryngology-Head and Neck Surgery. 2023.
Medication Comparisons
Compare medications used to treat Otosclerosis 1 C4551901. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy